Biotech Business Daily (AMLN, CERS, LLY, DNA, GTOP, IMCL)
Amylin Pharmaceuticals (NASDAQ: AMLN) reported first quarter losses of $68.8 million, or $0.51 EPS, wider than the $49.4 million in the first quarter of 2007. Losses are credited to a ...Read Full Story »

